Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Murray

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Trends in Pharmacological Sciences|March 31, 2012
Experiences in fragment-based drug discoveryChristopher W Murray, Marcel L Verdonk, David C Rees
Progress in Biophysics and Molecular Biology|October 1, 2014
Efficient exploration of chemical space by fragment-based screeningRichard J Hall, Paul N Mortenson, Christopher W Murray
Journal of Medicinal Chemistry|July 18, 2017
The Fragment Network: A Chemistry Recommendation Engine Built Using a Graph DatabaseRichard J Hall, Christopher W Murray, Marcel L Verdonk
Nature Reviews. Drug Discovery|August 3, 2004
Fragment-based lead discoveryDavid C Rees, Miles Congreve, Christopher W Murray, et al.
Nature Reviews. Drug Discovery|July 13, 2013
The 'rule of three' for fragment-based drug discovery: where are we now?Harren Jhoti, Glyn Williams, David C Rees, et al.
Journal of Molecular Biology|September 29, 2004
Apo and inhibitor complex structures of BACE (beta-secretase)Sahil Patel, Laurent Vuillard, Anne Cleasby, et al.
Drug Discovery Today|July 19, 2005
Fragment-based lead discovery: leads by designRobin A E Carr, Miles Congreve, Christopher W Murray, et al.
Journal of Medicinal Chemistry|October 15, 2016
Fragment-to-Lead Medicinal Chemistry Publications in 2015Christopher N Johnson, Daniel A Erlanson, Christopher W Murray, et al.
Proteins|January 15, 2005
Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteinsStewart B Kirton, Christopher W Murray, Marcel L Verdonk, et al.
Journal of Computer-Aided Molecular Design|June 27, 2003
Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidaseLouise Birch, Christopher W Murray, Michael J Hartshorn, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Trends in Pharmacological Sciences|March 31, 2012
Experiences in fragment-based drug discoveryChristopher W Murray, Marcel L Verdonk, David C Rees
Progress in Biophysics and Molecular Biology|October 1, 2014
Efficient exploration of chemical space by fragment-based screeningRichard J Hall, Paul N Mortenson, Christopher W Murray
Journal of Medicinal Chemistry|July 18, 2017
The Fragment Network: A Chemistry Recommendation Engine Built Using a Graph DatabaseRichard J Hall, Christopher W Murray, Marcel L Verdonk
Nature Reviews. Drug Discovery|August 3, 2004
Fragment-based lead discoveryDavid C Rees, Miles Congreve, Christopher W Murray, et al.
Nature Reviews. Drug Discovery|July 13, 2013
The 'rule of three' for fragment-based drug discovery: where are we now?Harren Jhoti, Glyn Williams, David C Rees, et al.
Journal of Molecular Biology|September 29, 2004
Apo and inhibitor complex structures of BACE (beta-secretase)Sahil Patel, Laurent Vuillard, Anne Cleasby, et al.
Drug Discovery Today|July 19, 2005
Fragment-based lead discovery: leads by designRobin A E Carr, Miles Congreve, Christopher W Murray, et al.
Journal of Medicinal Chemistry|October 15, 2016
Fragment-to-Lead Medicinal Chemistry Publications in 2015Christopher N Johnson, Daniel A Erlanson, Christopher W Murray, et al.
Proteins|January 15, 2005
Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteinsStewart B Kirton, Christopher W Murray, Marcel L Verdonk, et al.
Journal of Computer-Aided Molecular Design|June 27, 2003
Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidaseLouise Birch, Christopher W Murray, Michael J Hartshorn, et al.
Pageof 7